Product Images Azacitidine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Azacitidine NDC 68001-527 by Bluepoint Laboratories, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Carton - azacitidine for inj carton

Carton - azacitidine for inj carton

This is a description of Azacitidine, a medication that comes in a blue box with a file name 51 1966 0 729146-Azacitidine Inj-100mg-Box. It is intended for subcutaneous and intravenous use, and caution is advised as it is a cytotoxic agent. The medication comes in a single-dose vial containing 100mg of azacitidine and 100mg of mannitol in lyophilized powder form which must be diluted before use. Detailed prescribing information should be consulted for administration and dosage instructions. Vials should be stored between 15° to 30°C, and unused portions should be discarded. The label also includes information about the manufacturer's details and Mfg. Lic. No. The product has dimensions of 145mm in length, 45mm in width, and 75mm in height.*

label - azacitidine for inj label

label - azacitidine for inj label

This is a description of a medication called Azacitidine. It comes in a single-use vial that contains 100mg of Azacitidine and 100mg of mannitol. The prescribing information should be consulted for the proper dosage and administration. The medication is for injection and any unused portion should be discarded. The medication must be stored at a temperature between 15°C to 30°C (59°F to 86°F). It is manufactured by Intas Pharmaceuticals Limited, located in Ahmedabad, India. This medication is a cytotoxic agent and should only be used under the direction and supervision of a healthcare professional.*

Kaplan-Meier Curve of Time to Death from Any Cause: (Intent-to-Treat Population) - azacitidine for inj plot

Kaplan-Meier Curve of Time to Death from Any Cause:  (Intent-to-Treat Population) - azacitidine for inj plot

This is a survival analysis of two treatments (AZA and CCR) for an unspecified medical condition. The Log-Rank p-value indicates that there is a statistically significant difference in survival between the two treatments, with AZA being associated with better survival outcomes. The Hazard Ratio (HR) is also reported, with 95% confidence interval. The graph shows the proportion of patients surviving over time, with time measured in months. The number of patients at risk at each time point is also displayed.*

Azacitidine Structural Formula - azacitidine for inj structure

Azacitidine Structural Formula - azacitidine for inj structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.